SCHOON-MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SCHOON-MED
Largest movements
- Tangible fixed assets -€76,739
down €76,739 (-6.3%), from €1.2m to €1.1m
of which Land and buildings: -€72,754
- Cash +€12,971
up €12,971 (+23.0%), from €56,338 to €69,309
mainly Depreciation (+€85,269) and Current portion of long-term debt (+€6,596)
- Debts after one year -€72,380
down €72,380 (-6.3%), from €1.1m to €1.1m
- Gross operating margin -€9,989
down €9,989 (-9.2%), from €108,377 to €98,387
- Financial income +€1,557
up €1,557 (+630%), from €247 to €1,804
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,279,710 | €1,215,342 | -€64,368 | -5.0% |
| Fixed assets | 21/28 | €1,222,464 | €1,145,726 | -€76,739 | -6.3% |
| Tangible fixed assets | 22/27 | €1,222,464 | €1,145,726 | -€76,739 | -6.3% |
| Land and buildings | 22 | €1,176,422 | €1,103,668 | -€72,754 | -6.2% |
| Plant, machinery and equipment | 23 | €42,494 | €39,984 | -€2,511 | -5.9% |
| Furniture and vehicles | 24 | €3,548 | €2,074 | -€1,474 | -41.5% |
| Current assets | 29/58 | €57,246 | €69,617 | +€12,371 | +21.6% |
| Amounts receivable within one year | 40/41 | €0 | €308 | +€308 | |
| Trade receivables | 40 | €0 | €308 | +€308 | |
| Cash at bank and in hand | 54/58 | €56,338 | €69,309 | +€12,971 | +23.0% |
| Deferred charges and accrued income | 490/1 | €908 | €0 | -€908 | -100% |
| Total equity and liabilities | 10/49 | €1,279,710 | €1,215,342 | -€64,368 | -5.0% |
| Equity | 10/15 | €64,092 | €64,986 | +€894 | +1.4% |
| Contributions | 10/11 | €61,500 | €61,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €2,592 | €3,486 | +€894 | +34.5% |
| Amounts payable | 17/49 | €1,215,618 | €1,150,356 | -€65,262 | -5.4% |
| Amounts payable after more than one year | 17 | €1,149,645 | €1,077,265 | -€72,380 | -6.3% |
| Financial debts | 170/4 | €1,149,645 | €1,077,265 | -€72,380 | -6.3% |
| Amounts payable within one year | 42/48 | €65,973 | €73,091 | +€7,118 | +10.8% |
| Current portion of amounts payable after more than one year | 42 | €65,784 | €72,380 | +€6,596 | +10.0% |
| Trade debts | 44 | €189 | €711 | +€522 | +276% |
| Suppliers | 440/4 | €189 | €711 | +€522 | +276% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €84,262 | €85,269 | +€1,007 | +1.2% |
| Other operating charges | 640/8 | €2,830 | €2,943 | +€114 | +4.0% |
| Gross operating margin | 9900 | €108,377 | €98,387 | -€9,989 | -9.2% |
| Operating profit (loss) | 9901 | €21,285 | €10,175 | -€11,110 | -52.2% |
| Financial income | 75/76B | €247 | €1,804 | +€1,557 | +630% |
| Recurring financial income | 75 | €247 | €1,804 | +€1,557 | +630% |
| Financial charges | 65/66B | €11,498 | €10,860 | -€638 | -5.6% |
| Recurring financial charges | 65 | €11,498 | €10,860 | -€638 | -5.6% |
| Profit (loss) for the period before taxes | 9903 | €10,034 | €1,119 | -€8,915 | -88.8% |
| Income taxes | 67/77 | - | €225 | +€225 | |
| Profit (loss) for the period | 9904 | €10,034 | €894 | -€9,139 | -91.1% |
| Profit (loss) for the period to be appropriated | 9905 | €10,034 | €894 | -€9,139 | -91.1% |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.